274 related articles for article (PubMed ID: 33341157)
1. Remdesivir for COVID-19 in Europe: will it provide value for money?
Dal-Ré R; Banzi R; Georgin-Lavialle S; Porcher R; Sofat R; Zeitlinger M; Rosendaal FR
Lancet Respir Med; 2021 Feb; 9(2):127-128. PubMed ID: 33341157
[No Abstract] [Full Text] [Related]
2. Missed Opportunities on Emergency Remdesivir Use.
Sarpatwari A; Kaltenboeck A; Kesselheim AS
JAMA; 2020 Jul; 324(4):331-332. PubMed ID: 32579163
[No Abstract] [Full Text] [Related]
3. Economic evaluation of remdesivir for the treatment of severe COVID-19 patients in China under different scenarios.
Jiang Y; Cai D; Chen D; Jiang S; Si L; Wu J
Br J Clin Pharmacol; 2021 Nov; 87(11):4386-4396. PubMed ID: 33855727
[TBL] [Abstract][Full Text] [Related]
4. 'A very, very bad look' for remdesivir.
Cohen J; Kupferschmidt K
Science; 2020 Nov; 370(6517):642-643. PubMed ID: 33154114
[No Abstract] [Full Text] [Related]
5. A Potential Antiviral Treatment for COVID-19: Remdesivir.
O'Malley PA
Clin Nurse Spec; 2020; 34(6):257-260. PubMed ID: 33009111
[No Abstract] [Full Text] [Related]
6. Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact.
Béraud G; Timsit JF; Leleu H
PLoS One; 2022; 17(1):e0262462. PubMed ID: 35020746
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 updates: Remdesivir (Veklury) in high-risk outpatients with COVID-19.
Med Lett Drugs Ther; 2022 Feb; 64(1644):31-32. PubMed ID: 35171898
[No Abstract] [Full Text] [Related]
8. Remdesivir in The Treatment of COVID-19.
Rosenberg K
Am J Nurs; 2021 Jan; 121(1):55. PubMed ID: 33350698
[TBL] [Abstract][Full Text] [Related]
9. Origins and Ownership of Remdesivir: Implications for Pricing.
Lee CC; Darrow JJ; Avorn J; Kesselheim AS
J Law Med Ethics; 2020 Sep; 48(3):613-618. PubMed ID: 33021169
[No Abstract] [Full Text] [Related]
10. Early remdesivir treatment in COVID-19: Why wait another day?
Cubeddu LX; Cubeddu RJ
J Med Virol; 2021 Jul; 93(7):4078-4080. PubMed ID: 33511655
[No Abstract] [Full Text] [Related]
11. Remdesivir: a pendulum in a pandemic.
Schwartz IS; Heil EL; McCreary EK
BMJ; 2020 Nov; 371():m4560. PubMed ID: 33234523
[No Abstract] [Full Text] [Related]
12. Update Alert 2: Remdesivir for Adults With COVID-19.
Kaka AS; MacDonald R; Linskens EJ; Wilt TJ
Ann Intern Med; 2021 Dec; 174(12):W114-W115. PubMed ID: 34606312
[No Abstract] [Full Text] [Related]
13. Remdesivir for patients with COVID-19.
Wu PE; Morris AM
CMAJ; 2021 Jan; 193(4):E125. PubMed ID: 33408097
[No Abstract] [Full Text] [Related]
14. Remdesivir for the treatment of COVID-19 in pregnancy.
Lampejo T
J Med Virol; 2021 Jul; 93(7):4114-4119. PubMed ID: 33788273
[No Abstract] [Full Text] [Related]
15. Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
Chhatwal J; Basu A
Value Health; 2022 May; 25(5):697-698. PubMed ID: 35315330
[No Abstract] [Full Text] [Related]
16. Remdesivir-based therapy improved the recovery of patients with COVID-19 in the multicenter, real-world SARSTer study.
Flisiak R; Zarębska-Michaluk D; Berkan-Kawińska A; Tudrujek-Zdunek M; Rogalska M; Piekarska A; Kozielewicz D; Kłos K; Rorat M; Bolewska B; Szymanek-Pasternak A; Mazur W; Lorenc B; Podlasin R; Sikorska K; Oczko-Grzesik B; Iwaszkiewicz C; Szetela B; Pabjan P; Pawłowska M; Tomasiewicz K; Polańska J; Jaroszewicz J
Pol Arch Intern Med; 2021 Jan; 131(1):103-110. PubMed ID: 33382547
[No Abstract] [Full Text] [Related]
17. Assessing the evidence on remdesivir.
Trøseid M; Hites M; Barratt-Due A; Ader F; Yazdanpanah Y
Lancet Infect Dis; 2021 Dec; 21(12):1630-1631. PubMed ID: 34838222
[No Abstract] [Full Text] [Related]
18. Safety profile of the antiviral drug remdesivir: An update.
Fan Q; Zhang B; Ma J; Zhang S
Biomed Pharmacother; 2020 Oct; 130():110532. PubMed ID: 32707440
[No Abstract] [Full Text] [Related]
19. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).
Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Abraham GM; Jokela JA; Forciea MA; Miller MC; Humphrey LL; ; Centor RM; Andrews R; Haeme R
Ann Intern Med; 2021 May; 174(5):673-679. PubMed ID: 33560862
[TBL] [Abstract][Full Text] [Related]
20. Commentary: "Emergency Use Authorization for Remdesivir: A Pediatric Perspective".
Noel GJ; Connor E
Pediatr Infect Dis J; 2020 Sep; 39(9):e234. PubMed ID: 32639464
[No Abstract] [Full Text] [Related]
[Next] [New Search]
